"First oral GLP-1 treatment for weight management"
But the base price is lower
Semaglutide may be unsuitable or require additional caution in patients who: are pregnant, breastfeeding or trying to conceive have a history of pancreatitis have severe gastrointestinal disease have delayed stomach emptying have significant kidney or liver impairment use insulin or medicines that can cause hypoglycaemia have diabetic retinopathy have an active or previous eating disorder have experienced a serious allergic reaction to semaglutide already use another GLP-1 or GIP/GLP-1 medicine are due to undergo surgery, sedation or general anaesthesia These factors are not all automatic exclusions
At the time of booking your appointment, a member of our team can discuss the ways that tirzepatide can benefit you
When to contact your WeightCare physician Most side effects are manageable and expected
These findings indicate that clinicians can now recognise semaglutide as a vascular protective medication, with benefits that extend beyond lowering weight or A1C, said Subodh Verma (University of Toronto, Toronto, Canada), senior author of the STRIDE trial
